In addition, aberrant NRF2 activation is increased via B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation, which increases the acquired resistance and promotes the survival of Top II poison-resistant cancer cells. The gene discussed is BRAF; the disease is cancer.